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Microbial pattern molecules in the intestine play
immunoregulatory roles via diverse pattern recogni-
tion receptors. However, the role of the cytosolic
DNA sensor AIM2 in themaintenance of intestinal ho-
meostasis is unknown. Here, we show that Aim2/
mice are highly susceptible to dextran sodium sul-
fate-induced colitis that is associated with microbial
dysbiosis as represented by higher colonic burden
of commensal Escherichia coli. Colonization of
germ-freemicewithAim2/mousemicrobiota leads
to higher colitis susceptibility. In-depth investigation
of AIM2-mediated host defense responses reveals
that caspase-1 activation and IL-1b and IL-18 pro-
duction are compromised in Aim2/ mouse colons,
consistent with defective inflammasome function.
Moreover, IL-18 infusion reduces E. coli burden as
well as colitis susceptibility in Aim2/ mice. Altered
microbiota in inflammasome-defectivemice correlate
with reducedexpressionof several antimicrobial pep-
tides in intestinal epithelial cells. Together, these find-
ings implicate DNA sensing by AIM2 as a regulatory
mechanism for maintaining intestinal homeostasis.
INTRODUCTION
The intestinal mucosal immune system of mammals evolved
to coexist with densely populated microorganisms that reside
in the intestinal lumen. The central physiological process for ho-
meostatic immune response in the gut is the recognition of path-
ogen-associated molecular patterns (PAMPs) by host pattern
recognition receptors (PRRs). There are several evolutionary
conserved PRRs including Toll-like receptors (TLRs), NOD-like
receptors (NLRs), RIG-I-like receptors (RLRs), C-type lectin-like
receptors (CLRs), andHIN-200 family receptors. Defects in path-
ogen sensing systems lead todysregulated immune responses in
the intestine, resulting in the induction of intestinal inflammatory1922 Cell Reports 13, 1922–1936, December 1, 2015 ª2015 The Autdisorders such as inflammatory bowel disease (IBD) and colo-
rectal cancer (Cho, 2008). Clinical and experimental studies
have shown that dysfunctions in several TLRs (TLR2, TLR4, and
TLR9) andNLRs (NOD2, NLRP3, NLRP6, and NLRP12) are asso-
ciated with the pathogenesis of intestinal inflammation and
tumorigenesis (Chen et al., 2008; Elinav et al., 2011; Hugot
et al., 2001; Katakura et al., 2005; Maeda et al., 2005; Rakoff-Na-
houm et al., 2004; Vijay-Kumar et al., 2007; Villani et al., 2009;
Zaki et al., 2010a, 2011b). However, the precise mechanisms of
the regulation of intestinal homeostasis by these pathogen sen-
sors are not clearly defined, and the functions of the majority of
PRRs in intestinal physiology have yet to be explored.
Absent in melanoma 2 (AIM2), a member of interferon-induc-
ible gene HIN-200 family, has been implicated as a cytosolic
sensor of DNA (B€urckst€ummer et al., 2009; Fernandes-Alnemri
et al., 2009; Hornung et al., 2009). Recent studies have under-
scored the importance of AIM2-mediated sensing of microbial
DNA in host defense responses against bacterial and viral infec-
tions caused by Listeria monocytogenes, Francisella tularensis,
Streptococcus pneumoniae, and murine cytomegalovirus
(Fang et al., 2014; Fernandes-Alnemri et al., 2010; Jones et al.,
2010; Kim et al., 2010; Park et al., 2014; Rathinam et al., 2010).
Structurally, AIM2 contains an N-terminal pyrin domain (PYD)
and a C-terminal oligonucleotide binding HIN domain. When
cytosolic dsDNA binds to its HIN domain, AIM2 recruits
apoptosis speck-like protein containing a caspase recruitment
domain (ASC) and caspase-1 to form amolecular platform called
the inflammasome. In addition to AIM2, at least three NLR family
members—NLRP1, NLRP3, and NLRC4—are known to activate
the inflammasome in biological systems (Lamkanfi and Dixit,
2009). Inflammasome-mediated activation of caspase-1 is
required to cleave pro-IL-1b and pro-IL-18 into their active
forms. Mounting evidence points to the critical roles caspase-1
and other inflammatory caspases play in regulating intestinal
inflammation and tumorigenesis (Allen et al., 2010; Dupaul-Chic-
oine et al., 2010; Elinav et al., 2011; Salcedo et al., 2010; Zaki
et al., 2010a). We and others previously demonstrated that the
NLRP3 inflammasome regulates intestinal inflammation and
tumorigenesis in mice (Allen et al., 2010; Hirota et al., 2011;
Zaki et al., 2010a, 2010b). Recent studies showed that thehors
inflammasome in the gut can be activated by other PRRs, such
as NLRP1 and NLRP6, which also contribute to intestinal ho-
meostasis (Elinav et al., 2011; Williams et al., 2015). However,
until now, DNA-dependent activation of the AIM2 inflammasome
and its physiological relevance to intestinal homeostasis in the
gut has not been reported.
Here, we investigated the physiological function of AIM2 in the
gut. Our results show thatAim2/mice are highly susceptible to
DSS-induced colitis. AIM2-mediated protection against colonic
inflammation was associated with its function as an activator
of the inflammasome, since caspase-1 activation and IL-18 pro-
duction were remarkably attenuated in the absence of AIM2.
Interestingly, the colons of Aim2/ and other inflammasome-
defective mice, e.g., Nlrp3/, caspase-1/ (caspase1/11/),
and Il18/, contain significantly higher loads of Escherichia
coli, an indication of dysbiosis in their gut. Transfer of gut micro-
biota from Aim2/ to wild-type (WT) mice confers higher colitis
susceptibility in the WT mice, suggesting that the AIM2 inflam-
masome plays a critical role in the regulation of intestinal inflam-
mation via shaping the intestinal microbial ecology. Further
investigation revealed that the AIM2 inflammasome regulates
the expression of antimicrobial peptides (AMPs), including
C-type lectins (Reg3b and Reg3g), calprotectin (S100A8 and
S100A9), and lipocalin 2 (Lcn2) by intestinal epithelial cells. Over-
all, our study elucidates a major inflammasome activation
pathway in the intestine that involves the DNA sensor AIM2
and offers further insights into the mechanism of inflamma-
some-mediated protection against intestinal inflammation.
RESULTS
AIM2 Protects Mice from DSS-Induced Colitis
Previous studies have shown that Aim2 is highly expressed in the
large intestine (Cridland et al., 2012). Our real-time PCR analyses
confirm that Aim2 is ubiquitously expressed in the colon (Figures
S1A and S1B). To investigate the physiological function of AIM2
in the colon, we induced colitis in Aim2/mice (Rathinam et al.,
2010) by feeding them 3%DSS-containing water for 5 days. Co-
litis susceptibility inAim2/ andWTmicewas evaluated daily by
monitoring body weight and measuring clinical features such as
diarrhea and occult stool bleeding. Aim2/ mice lost signifi-
cantly more body weight and exhibited increased diarrhea and
rectal bleeding compared to WT mice (Figures 1A–1C). Mice
were sacrificed at day 8 and examined macroscopically and
microscopically for inflammatory changes. Aim2/ mouse co-
lons were significantly shorter compared toWTmice (Figure 1D).
This was further supported by histological analysis of H&E-
stained whole colon tissue sections (Figure 1E). Much of the
distal colon inAim2/mice showed complete crypt destruction,
ulceration, and submucosal edema, whichwere far less severe in
WT mice (Figures 1E and 1F). Histopathological analyses
demonstrated significantly higher scores for inflammation, ulcer-
ation, and crypt distortion in the middle and distal part of the
Aim2/mouse colon at day 8 post DSS administration (Figures
1F and 1G). Notably, Aim2/mice exhibited normal colonic his-
topathology prior to DSS administration (Figure 1E), and the
expression of Aim2 was not altered during colitis (Figures S1C–
S1E). Taken together, AIM2 is a critical regulator of intestinalCell Rehomeostasis, and Aim2-deficiency leads to higher colitis sus-
ceptibility and severity in mice.
Colonic Injury Leads to Hyper-Inflammation in
Aim2/ Mice
Although cytokine production in the intestine is essential for
repair and healing of the injured epithelium, overwhelming pro-
duction of cytokines and chemokines trigger pathologicmucosal
tissue injury and inflammatory disorders (Zaki et al., 2011a).
Therefore, the types and levels of different mediators determine
the fate of colonic inflammation and damage. To understand
whether AIM2 signaling regulates cytokine production, we
measured the expression of IL-1b, IL-1a, IL-6, KC, TNFa,
MIP2, CCL2, and CXCL10 in colon tissues collected from wild-
type and Aim2/ mice over the course of colitis (days 0, 3, 5,
and 8). Although the initial (day 0) expression of proinflammatory
cytokines and chemokines were comparable, IL-1a, IL-1b, IL-6,
KC, and MIP2 were significantly increased in Aim2/ mice at
day 5 and day 8 (Figure 2A). In addition, CXCL10 and CCL2
were also overexpressed in Aim2/mouse colons at day 8 (Fig-
ure 2A). Elevated KC and IL-6 levels in Aim2/mouse colon ho-
mogenates were confirmed by ELISA at day 5 and day 8 of colitis
(Figure 2B). However, type I interferons were not regulated
by AIM2 (Figure S2A). MIP2, KC, and CCL2 are involved in
the recruitment and migration of macrophages, neutrophils,
and lymphocytes. Consistent with the accumulation of these
chemokines in Aim2/ mouse colons, we observed greater
macrophage infiltration as measured by immunohistochemistry
(Figure 2C). Furthermore, the inflammatory signaling pathway
ERK showed elevated activation in Aim2/ mouse colons
collected at day 5 and day 8 post DSS as compared to those
inWTmice (Figure 2D). However, we did not observe differences
in epithelial cell death between WT and Aim2/ mice during
colitis as measured by TUNEL assay (Figures S2B and S2C).
AIM2 Regulates Intestinal Microbiota
Colitis is initiated by the invasion of gut commensal flora into the
lamina propria, driving the activation of immune cells. To inves-
tigate the possibility that increased inflammation in Aim2/
mice is due to increased penetration of the intestinal
commensal flora into colonic mucosa during DSS-colitis, we
measured the number of culturable bacteria in the colon tissue
at day 8 after DSS administration. Colon homogenates were
cultured onto brain heart infusion (BHI) and blood agar, under
aerobic and anaerobic conditions, respectively. There were
significantly greater aerobic and anaerobic/facultative anaer-
obic bacteria present in the Aim2/ mouse colon tissue
compared to WT mice (Figure 3A). Culture of fecal homoge-
nates revealed a higher bacterial burden in the colonic lumen
of Aim2/ mice compared to those of WT mice (Figure 3B).
Notably, no bacteria were detected in WT or Aim2/ mouse
colon tissues (data not shown), and there were no significant
differences in total stool bacterial burden prior to colitis induc-
tion (Figures S3A and S3B).
These above findings led us to hypothesize that increased
colitis susceptibility in Aim2/mice is associated with dysregu-
lated host defense response against pre-existing commensal
bacteria. Thus, we treated a cohort of WT and Aim2/ miceports 13, 1922–1936, December 1, 2015 ª2015 The Authors 1923
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Figure 1. Aim2/ Mice Are Susceptible to DSS-Induced Colitis
(A–E)WT (n = 17) andAim2/ (n = 12) mice were fedwith 3%DSS for 5 days, followed by regular drinking water for 3 days. Body weight (A), stool consistency (B),
and rectal bleeding (C) were scored daily. (D)Micewere sacrificed on day 8 tomeasure colon length. (E) Colon tissues collected from healthymice (day 0) or at day
8 were stained with H&E. Scale bars, 100 mm.
(F and G) Semiquantitative scoring of histopathology (n = 8–10). Data represent mean ± SEM of a representative experiment; *p < 0.05, **p < 0.01, ***p < 0.001.
See also Figure S1.with a cocktail of broad-spectrum antibiotics containing vanco-
mycin, neomycin, ampicillin, and metronidazole for 4 weeks as
described (Rakoff-Nahoum et al., 2004). Antibiotic-treated or
untreated WT and Aim2/ mice were then fed with 3% DSS for
5 days. Interestingly, antibiotic-treated WT and Aim2/ mice
lost minimum body weight as compared to untreated mice (Fig-
ure 3C). Although untreated Aim2/ mice lost significantly
greater body weight, exhibited shorter colons, and suffered1924 Cell Reports 13, 1922–1936, December 1, 2015 ª2015 The Autfromseverecolonic injury and inflammationascompared to those
ofWTmice, antibiotic treatment completely attenuated the differ-
ences betweenAim2/ andWTmice at day 8 after DSS (Figures
3C–3E). Consistently, the production of proinflammatory cyto-
kines IL-6, KC, MIP2, and CCL2 was reduced to baseline in anti-
biotic-treatedWTandAim2/mousecolons (FigureS3C). These
findings support the idea that increased colitis in Aim2/mice is
due to bacterial overgrowth in the colon during acute colitis.hors
AB
C D
Figure 2. AIM2-Deficiency Leads to Increased Inflammation in the Colon
WT and Aim2/ mice were fed with 3% DSS in drinking water for 5 days, followed by regular drinking water for 3 days.
(A) Real-time PCR analyses of IL-1a, IL-1b, IL-6, TNF-a, MIP2, Cxcl-10, and Ccl2 expression in colons collected at days 0, 3, 5, and 8 after DSS.
(B) Colon homogenates were analyzed for the level of KC and IL-6 by ELISA. Data represent mean ± SEM; n = 7–10/group; *p < 0.05, **p < 0.01.
(C) Colon tissues collected at day 8 was fixed in formalin and immunostained for themacrophagemarker F4/80. Brown colors indicate F4/80-positive cells. Scale
bars, 100 mm.
(D) Whole colon homogenates were analyzed for the activation of ERK by western blotting.
See also Figure S2 and Table S1.
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Figure 3. AIM2 Protects Host against Colitis via Regulation of Colonic Microbiota
WT and Aim2/ mice were fed with 3% DSS in drinking water for 5 days.
(A) Colon homogenates collected at day 8 after DSS were plated on BHI and Blood agar and incubated in aerobic (BHI agar) or anaerobic (Blood agar) conditions
at 37C.
(B) Feces collected fromWT and Aim2/mice at day 8 after DSS administration were diluted in PBS and plated on BHI and Blood agar. After overnight culture at
37C, CFU was counted.
(C–E) WT and Aim2/mice were treated with a combination of antibiotics or left untreated for 4 weeks and then administered with 3% DSS for 5 days. (C) Body
weight changes were monitored daily. (D) Mice were sacrificed at day 8 and colon lengths were measured. (E) Colons collected at day 8 after DSS administration
(legend continued on next page)
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The composition of bacterial species present in the gut lumen
regulates downstream immune responses and affects colitis
severity. Accumulating evidence suggests that the presence of
certain bacterial species in the gut, such as E. coli, Bacteroides,
Clostridia, and Firmicutes, augments experimental colitis in mice
(Frank et al., 2007; Li et al., 2015; Martinez-Medina and Garcia-
Gil, 2014; Walters et al., 2014). A previous study showed that
colitis susceptibility in Nlrp6/, ASC/, and Il18/ mice was
associated with increased number of Prevotellaceae and TM7
(Elinav et al., 2011). To examine the possibility that disease
severity in Aim2/ mice was linked to the colonic load of
Prevotellaceae and TM7, we measured the relative abundance
of 16S rDNA specific to these bacteria by real-time PCR. Inter-
estingly, there was no significant difference in Prevotellaceae
or TM7 between Aim2/ and WT mice (Figure 3F). In addition,
we also measured 16S rDNA levels for other known mouse gut
commensal and colitogenic bacteria such as Bacteroides,
E. coli, Enterobacteriaceae, Lactobacillus, mouse intestinal
Bacteroides (MIB), Eubacterium rectale (EREC), segmented
filamentous bacteria (SFB), Staphylococcus, Streptococcus,
Enterococcus, Clostridium, Prophyromonas, and Bifidobacteria.
With the notable exception of E. coli and Enterobacteriaceae,
none of those commensal bacteria were significantly different
between the two groups of mice (Figures 3F and 3G). However,
E. coli- and Enterobacteriaceae-specific 16S rDNA was several
thousand folds higher in Aim2/ mouse feces compared to
those in WT mice (Figure 3G). The overgrowth of E. coli was
confirmed by colony forming units (CFU) assay of fecal homog-
enates on MacConkey agar, a selective media for Enterobacter-
iaceae. While E. coli was barely detectable in WT mouse stool,
Aim2/mice harbored 106 CFU of E. coli per gram of feces (Fig-
ure 3H). DSS administration further enhanced E. coli burden
in Aim2/ mice (Figures 3I and 3J). MacConkey agar colonies
were unambiguously identified as E. coli by MALDI-TOF
(data not shown). Other known colitogenic bacteria such asBac-
teroides, SFB,Clostridium,Bifidobacterium, Prevotellaceae, and
TM7 were not significantly different, even after colitis induction,
in either set of mice (Figure S3D). However, increased growth
of E. coli reflects an alteration of microbial composition in the in-
testine of Aim2/ mice.
Dysbiosis Regulates Colitis Susceptibility in Aim2-
Deficient Mice
Wepostulated that dysbiosis, as evidenced by increased growth
of E. coli in Aim2/mouse colons, exacerbates colitis develop-
ment. To verify this hypothesis, we generated Aim2 heterozy-
gous mice by breeding of Aim2/ female and WT male mice.
Littermate WT (WT-lit) and Aim2/ (Aim2/-lit) mice obtained
from breeding of Aim2 heterozygous mice were then adminis-were examined histologically. Scale bars, 100 mm. Data represent mean ± SEM
**p < 0.01, ***p < 0.001.
(F and G) DNA was isolated from feces of healthy WT and Aim2/ mice. Bacteri
Data represent mean ± SEM (n = 8–10/group); ***p < 0.001.
(H and I) Stools collected from WT and Aim2/mice before or 8 days after DSS
represent mean ± SEM; ***p < 0.001.
(J) 16S rRNA gene sequences of E. coli and Enterobacteriaceae in DNA isolated
See also Figure S3 and Table S2.
Cell Retered with 3%DSS for 5 days.WT-lit andAim2/-lit mice gener-
ated in this way should harbor intestinal flora originating from
Aim2/mice. Interestingly, WT-lit mice developed pronounced
colitis that was phenotypically very similar to the colitis in
Aim2/mice as evidenced by body weight loss, clinical scores
for diarrhea and rectal bleeding, and shortening of the colon (Fig-
ures 4A–4C). Histopathological examination revealed that
inflammation, ulceration, edema, and crypt destruction in WT-
lit mice were morphologically indistinguishable from that seen
in Aim2/-lit mice (Figure 4D). In agreement with comparable
colitis susceptibility in littermate mice, an equal burden of
E. coli was detected in WT-lit and Aim2/-lit mouse colons
(Figure 4E), and similar bacterial growth was observed between
WT-lit and Aim2/-lit mouse feces (Figures S4A and S4B).
The above results suggested that colitis susceptibility of
Aim2/micemight be transferable. To verify this, we co-housed
WT and Aim2/mice for 4 weeks. Although adult WTmice were
resistant to the maternal transfer of E. coli and failed to develop
severe colitis (Figures S4C–S4E), colitis susceptibility of co-
housed Aim2/mice was more mild than Aim2/mice housed
without WT mice (Figures S4D and S4E). This finding suggests
that unknownmicroflora transferred fromWTmice to co-housed
Aim2/mice plays a protective role against colitis, and exacer-
bated colitis in Aim2/ mice is partly driven by the lack of pro-
tective microbiota. To further confirm that altered microbiota is
responsible for increased colitis susceptibility in Aim2/ mice,
we colonized germ-free WT (GF) mice with microbiota present
in conventionally raised WT or Aim2/ mice. Two weeks after
colonization, E. coli burden in GF mice colonized with fecal
microbiota either from WT (GF-WT) or Aim2/ (GF-Aim2/)
mice was measured. While GF-Aim2/ mice harbored huge
E. coli burdens, no E. coli was detected in GF-WT mice (Fig-
ure 4F). Colitis was then induced in these two groups of mice
by feeding them with 2.5% DSS for 5 days. We observed that
GF-Aim2/ mice lost more than 25% of their body weight at
day 7 after DSS, while GF-WT mice were relatively resistant to
colitis as evaluated by body weight loss, clinical scores, and co-
lon length (Figures 4G–4I). Consistently, there was significantly
increased inflammation, production of proinflammatory cyto-
kines, and bacterial growth in GF-Aim2/ mouse colons (Fig-
ures 4J, 4K, S4F, and S4G). These results shed light on the
importance of DNA sensor AIM2 in the regulation of commensal
E. coli and other uncultured microorganisms that potentially
regulate intestinal homeostasis and colitis pathogenesis.
AIM2 Regulates the Expression of Antimicrobial
Peptides in the Colon
Intestinal epithelial cells produce antimicrobial effectors that play
a central role in the shaping of the gut microbial community and; n = 7–10 and representative of three independent experiments. *p < 0.05,
al 16S rRNA gene sequences were quantitatively measured by real-time PCR.
administration were diluted in PBS and plated on MacConkey agar plate. Data
from stool at day 8 post DSS were quantitatively measured by real-time PCR.
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Figure 4. Colitis Susceptibility in Aim2/ Mice Is Contributed by Altered Microbiota
(A–E) LittermateWT (WT-lit; n = 9) andAim2/ (Aim2/-lit; n = 7), non-littermateWT (n = 7) andAim2/ (n = 7)micewere fedwith 3%DSS for 5 days, followed by
regular drinking water for 3 days. Body weight (A) and stool consistency (B) were scored daily. Mice were sacrificed on day 8 to measure colon length (C) and
examined for histopathological changes in colon tissue by H&E staining (D). (E) Fecal pellets collected from healthy littermate WT and Aim2/mice were diluted
in PBS and cultured on MacConkey agar plate. Cfu of E. coli was counted.
(F–K) Germ-free (GF) mice were co-housed with either conventionally raised WT (GF-WT) or Aim2/ mice (GF-Aim2/) for 3 days. (F) Two weeks after colo-
nization, feces were homogenized in PBS and plated on MacConkey agar plate to count E. coli. (G–J) Microbiota-colonized GF mice (n = 4/group) were fed with
(legend continued on next page)
1928 Cell Reports 13, 1922–1936, December 1, 2015 ª2015 The Authors
protecting mucosal tissues from colonization and invasion of
commensal microorganisms (Gallo and Hooper, 2012). To un-
derstand why Aim2/mouse colons harbor altered microbiota,
we examined whether AIM2 regulates goblet cell function by us-
ing periodic acid-Schiff (PAS) staining (Figure 5A). We found the
number of PAS-positive cells was comparable between WT and
Aim2/mouse colons collected at day 5 following DSS-induced
colitis (Figure 5B). We also did not see any difference in the levels
of mucins (Muc1, Muc2, Muc3, and Muc4) present in WT and
Aim2/ mouse colons at baseline or following colitis induction
(Figure 5C). Autophagy in intestinal epithelial cells plays an
important role in regulating gut microbiota, but the conversion
of LC3-I into LC3-II in WT and Aim2/ was comparable both
pre- and post-induction of colitis (Figures S5A and S5B). Intesti-
nal epithelial cells also produce several AMPs, which either
directly exert cytotoxicity or inhibit bacterial growth by limiting
trace elements (Gallo and Hooper, 2012). We measured the
expression of AMPs, including mouse b-defensin 2 (mBD2),
Reg3g and Reg3b, S100A8 and S100A9, and Lcn2 in WT and
Aim2/ mouse colons at day 0 and day 3 following colitis
induction. Interestingly, while the expression of mBD2 and
Lcn2 in healthy (day 0) WT and Aim2/ mice was comparable,
the level of Reg3g, Reg3b, S100A8, and S100A9 was signifi-
cantly reduced in Aim2/ mouse colons as compared to those
of WT mice (Figure 5D). The expression of Reg3b, S100A8, and
S100A9 remained low in the early phases of colitis (day 3)
(Figure 5D). These results suggest that AIM2 may regulate the
bacterial burden of E. coli and Enterobacteriaceae via the pro-
duction of AMPs. However, expression of Reg3g, Reg3b,
S100A8, S100A9, and Lcn2 were upregulated in Aim2/ mice
during acute colitis (day 8) (Figure S5C). Higher expression of
these AMPs in Aim2/ mice during colitis may be associated
with higher bacterial burden since their expression in Aim2/
and WT mice was reduced to the basal level upon treatment
with antibiotics (Figure S5C).
AIM2 Is a Major Inflammasome Activator in the Colon
Previous studies have shown that the NLRP3 inflammasome
plays a protective role against experimental colitis (Allen et al.,
2010;Zaki et al., 2010a).Notably, caspase-1activation inNlrp3/
mice is onlypartially reducedbut notcompletely abrogatedduring
DSS-colitis (Figure S6A), suggesting that other mechanisms of
caspase-1 activation are active in the gut. We hypothesized that
the dsDNA from colonizing bacteria contributes to intestinal ho-
meostasis via activation of the AIM2 inflammasome. To test this
hypothesis, we measured caspase-1 activation in colon tissues
collected fromWT and Aim2/mice at different days during co-
litis. Interestingly, caspase-1 activation in Aim2/mouse colons
at days 0, 3, and 5 after DSS administration was significantly
reducedascompared toWTmousecolons (Figures6A–6D).How-
ever, a few Aim2/mice showed near normal caspase-1 activa-
tion in the colon, which may reflect the action of the NLRP3,
NLRP6, or other inflammasomes. We consistently observed3% DSS for 5 days. Body weight changes (G) and clinical scores for diarrhea (
administration. (J) Colons were fixed in 10% formalin and processed for H&E stain
Data represent mean ± SEM. *p < 0.05; **p < 0.01. Scale bars, 100 mm.
See also Figure S4 and Table S1.
Cell Resignificantly reduced levelsof IL-18,despiteenhancedexpression
of IL-18mRNA in inflamedcolons ofAim2/mice at days 3 and 5
after DSS administration (Figures 6E and S6B). Similarly, IL-1b
production was suppressed by the absence of AIM2 (Figure 6E).
Reduced activation of IL-1b and IL-18 in Aim2/ mouse colons
at healthy and colitic conditions was also seen in ex vivo colon
organ culture (Figure S6C). In agreement with the function of IL-
18 in epithelial cell proliferation (Dupaul-Chicoine et al., 2010;
Zaki et al., 2010a), we observed significantly reduced proliferation
of intestinal epithelial cells in Aim2/ mice during acute colitis
(day 5) but not at homeostasis (day 0) or delayed stage of colitis
(day 8) (Figures S6D andS6E). These data support the hypothesis
that bacterial dsDNA activates an AIM2-dependent inflamma-
some in the colon. To confirm that bacterial dsDNA present in
the colonic lumen can activate the AIM2 inflammasome, we iso-
lated DNA from mouse stool and transfected it into bone
marrow-derived macrophages (BMDM). While fecal DNA acti-
vated caspase-1 in WT BMDM, cleaved caspase-1 was not de-
tected in Aim2/ BMDM (Figure 6F). However, activation of the
NLRP3 inflammasome induced by LPS plus ATP or Nigericin
was completely normal inAim2/BMDM (FigureS6F). To under-
stand which cellular compartments are involved in AIM2-depen-
dent inflammasome activation, we isolated colonic epithelial cells
and lamina propria mononuclear cells (LPMN) from WT and
Aim2/ mice at day 5 post DSS. While caspase-1 activation
was significantly higher in WT epithelial cells compared to that
of Aim2/ mice (Figure 6G), it was barely detectable in LPMNs
of either background of mice (data not shown). The notion that
the epithelial compartment is the major site for the activation of
the AIM2 inflammasome is further supported by bone marrow
chimera studies. Chimeric mice having AIM2 in epithelial com-
partment, irrespective of the presence of AIM2 in myeloid cells
(WT > WT and Aim2/ > WT), developed less severe colitis as
compared to mice deficient in AIM2 in the epithelium (Aim2/ >
Aim2/ and WT > Aim2/) (Figures 6H and 6I). The observed
defect in inflammasome activation in Aim2/ mice was not
dependent on altered gutmicrobiota since inflammasome activa-
tion remaineddefective inAim2/mice co-housedwithWTmice
(Figure S6G).
The AIM2 Inflammasome Regulates Gut Microbiota and
Colitis Susceptibility via Production of AMPs
Next, we sought to determine whether AIM2 controls microbial
growth via the inflammasome. Therefore, we measured E. coli
burden in healthy WT, Aim2/, Nlrp3/, caspase-1/, Il1b/
and Il18/mice. The E. coli burden was significantly higher than
WT in all inflammasome-defective mice (Figures 7A and S7A);
however, E. coli burden in Il1b/ mice was significantly less
than other inflammasome-defective mice, suggesting that IL-
18 plays a major role in maintaining intestinal microbial homeo-
stasis. Dysregulated microbiota represented by increased
growth of E. coli in caspase-1/ and Il18/ mice was also
associated with increased colitis susceptibility as measured byH) were monitored daily. (I) Colon lengths were measured at day 7 after DSS
ing. (K) A part of the colon was analyzed for IL-6 and KC production by ELISA.
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Figure 5. AIM2 Regulates Production of Antimicrobial Peptides
WT and Aim2/ mice were fed with 3% DSS in drinking water for 5 days.
(A) Colons collected at day 5 after DSS were fixed in 10% formalin and cryosections were stained with PAS. Scale bars, 100 mm.
(B) PAS-positive cells per crypt were counted.
(C) Colons were collected at day 0 (n = 6/group) and day 5 (n = 6/group) after DSS administration. RNA was isolated and expression of Mucins (Muc1, Muc2,
Muc3, Muc4) was analyzed by qPCR.
(D) Expression of antimicrobial peptidesmBD2, Reg3b, Reg3g, S100a8, S100a9, and Lcn2 in colon tissues collected at day 0 and day 3 after DSS-administration
was measured by real-time PCR. Data represent mean ± SEM; n = 8–10/group; *p < 0.05, **p < 0.01.
See also Figure S5 and Table S1.body weight change, colon shortening, and clinical scores for
diarrhea (Figures 7B and S7B–S7D).
To understand whether dysbiosis in caspase-1/mice is also
due to the defects in AMP production, we measured the expres-
sion of mBD2, Reg3g, Reg3b, S100A8, S100A9, and Lcn2 at1930 Cell Reports 13, 1922–1936, December 1, 2015 ª2015 The Authomeostasis (day 0) or day 3 after DSS administration. Interest-
ingly, similar to Aim2/ mice (Figure 5D), the expression of
Reg3g, Reg3b, S100A8, and S100A9, was significantly reduced
in caspase-1/ mouse colons as compared to those in WT
mice (Figure 7C). However, the level of mBD2 and Lcn2 washors
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Figure 6. AIM2 Activates the Inflammasome in the Colon during Colitis
WT and Aim2/ mice were fed with 3% DSS in drinking water for 5 days.
(A–D) Colons collected at days 0, 3, 5, and 8 after DSS administration were homogenized and lysates were analyzed for caspase-1 activation by western blotting.
Cleaved caspase-1 (p20) is indicated by arrow.
(E) Colon homogenates were assayed for IL-1b and IL-18 ELISA. Data represent mean ± SEM; n = 7–10/group; *p < 0.05, **p < 0.01.
(F) BMDM collected fromWT or Aim2/mice were stimulated with 500 ng/ml LPS followed by transfected with either stool DNA or poly dA:dT (AIM2 ligand) for
4 hr. Cell lysates were analyzed for caspase-1 activation by western blotting.
(G) Epithelial cells were isolated from WT and Aim2/ mice at day 5 after DSS administration. Cell lysates were analyzed for caspase-1 activation by western
blotting.
(legend continued on next page)
Cell Reports 13, 1922–1936, December 1, 2015 ª2015 The Authors 1931
not different between caspase-1/ and WT mouse colons (Fig-
ure 7C). This observation is further supported by in vitro studies
showing that Reg3g, Reg3b, S100A9, and Lcn2 were induced
by both IL-1b and IL-18, and S100A8 was induced by IL-18 in
colonic epithelial cells (Figures 7D, S7E, and S7F). Similarly,
intestinal organoids expressed Reg3g, Reg3b, S100A9, and
Lcn2 in response to IL-1b and IL-18 (Figure S7G). Culture super-
natants of IL-1b- and IL-18-stimulated colon organ culture effec-
tively killed E. coli (Figure S7H). In vivo infusion of IL-18 led to a
dramatic reduction of colonic E. coli growth in Aim2/ mice
and protected them against DSS-induced colitis (Figures 7E
and 7F). IL-1b infusion also demonstrated a suppressive effect
on E. coli growth, but its effect was much less than that of IL-18
(Figures 7E and 7F). These results suggest that IL-18 produced
by the AIM2 inflammasome binds to the IL-18R on epithelial
and immune cells (Figures S7I and S7J), leading to the induction
of antimicrobial peptides that play a central role in regulating the
intestinal microbial ecology and inflammation (Figure 7G).
DISCUSSION
The surveillance of PAMPs by diverse PRRs expressed in intesti-
nal epithelial cells, aswell as immunecells, triggers ahomeostatic
immune response that allows for the peaceful coexistence of the
intestinal mucosal tissue and gut microbiota. Microbial DNA is
known to be sensed by TLR9, AIM2, and cGAS, leading to the
activation of NF-kB, inflammasome, and interferon signaling
pathways, respectively (Hornung et al., 2009; Roberts et al.,
2009; Sun et al., 2013; Tsujimura et al., 2004). TLR9-mediated
recognition of DNA in the intestine exerts a protective effect
against experimental colitis (Katakura et al., 2005; Rachmilewitz
et al., 2002). Although thephysiological relevanceofDNAsensing
by cGASduring intestinal inflammation has not been investigated
to date, type-I interferon signaling hasbeen shown to be critical in
regulating Paneth and T cell functions (Lee et al., 2012; Tschurt-
schenthaler et al., 2014). However, little is knownabout the role of
AIM2 as a DNA sensor in intestinal homeostasis. This study dem-
onstrates the involvement of AIM2 in DNA-dependent activation
of the intestinal mucosal immune system, which critically pro-
vides protection against intestinal inflammation.
Pathogenesis of inflammatory bowel diseases (IBD) such as
Crohn’s disease (CD) and ulcerative colitis involves both host ge-
netic susceptibility and altered gut microbiota. Several bacterial
species, including Escherichia coli, Bacteroides, Clostridia,
Bifidobacteria, and Firmicutes have been identified in clinical
samples from IBD patients, suggesting a role for these bacteria
in IBD pathogenesis (Frank et al., 2007; Li et al., 2015; Marti-
nez-Medina and Garcia-Gil, 2014; Walters et al., 2014). There-
fore, how host immune system regulates the growth of these
pathobionts is a long sought after goal in IBD research. A major
limitation of studies investigating the regulation of gut microbiota
in experimental models is the diversity of microflora in animals
from different laboratories. This may explain why we found no(H and I) Lethally irradiated WT and Aim2/mice were injected with either WT or A
Aim2/ (n = 6), Aim2/ >WT (6), and Aim2/ > Aim2/ (n = 6). Seven weeks aft
changes were monitored daily (H) and colon length was measured at day 7 (I). D
See also Figure S6.
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some-deficient mice, unlike what had been previously described
(Elinav et al., 2011). WT and all mutant mice included in this study
were obtained from Jackson Laboratory and they were housed
in the same animal facility at UT Southwestern. Thus, altered
microbiota as represented by increased growth of E. coli in
Aim2/, Nlrp3/, caspase-1/, and Il18/ mice is less likely
due to the difference in source, location, and other environ-
mental factors. Notably, we did not see similar level of E. coli
as of Aim2/ and caspase-1/mice in Nod2/ and Nlrp12/
mice, which are also susceptible to experimental colitis and
housed in the same animal facility (data not shown). However,
this study warrants that microbiota-related disease phenotypes
in experimental studies should be re-evaluated in different labo-
ratory settings.
Increased growth of E. coli in Aim2/ and other inflamma-
some-deficient mice is of great clinical significance. A growing
number of clinical studies demonstrate that E. coli resides in
the colonic and celiac mucosa of CD patients (Burke and
Axon, 1988; Darfeuille-Michaud et al., 2004; Martinez-Medina
and Garcia-Gil, 2014; Tabaqchali et al., 1978). Our understand-
ing of the genetic link between increased E. coli colonization
and CD susceptibility is poor. More than 100 loci associated
with CD susceptibility have been identified including NOD2,
ATG16L, IRGM, IL-23R, IL-10, and IL-18RAP (Cleynen et al.,
2013). However, a common mechanism of controlling E. coli
growth by these functionally diverse genes is less clear. Perhaps
defects in innate and adaptive immune system lead to an altered
host defense in the gut allowing increased growth of E. coli and
other Enterobacteriaceae. Supporting this view, increased
growth of Enterobacteriaceae was noted in T-bet/Rag2/
mice, a mice model for spontaneous colitis (Garrett et al.,
2010). An imbalance in the host immune response during inflam-
mation has also been shown to boost E. coli growth in the colon
(Winter et al., 2013). Our study demonstrates that the AIM2 in-
flammasome is a part of intestinal innate host defense against
an overgrowth of commensal E. coli. Notably, the colitis pheno-
type in Aim2/ mice is not solely dependent on E. coli since
co-housed Aim2/ mice developed attenuated colitis despite
higher E. coli burden, suggesting that other unidentified bacteria
that are transferred from WT to Aim2/mice during co-housing
may have protected Aim2/ mice against exacerbated colitis.
Although the inflammasome has emerged as a critical regu-
lator of intestinal homeostasis, our knowledge of how it regulates
the intestinal microbial community is limited. This study reveals
a pathway for the regulation of gut microbiota by inflamma-
some-mediated production of AMPs, including Reg3b, Reg3g,
S100A8, S100A9, and Lcn2. AMPs produced by intestinal
epithelial cells play critical roles in regulating the growth of the in-
testinal microbial community (Lai and Gallo, 2009; Ostaff et al.,
2013). Previous studies have elucidated a role for Reg3b in
host defense against Gram-negative bacteria (Stelter et al.,
2011; van Ampting et al., 2012). S100A8 and S100A9 act asim2/ bone marrow cells and divided into four groups: WT >WT (n = 8), WT >
er reconstitution, chimeric mice were fed with 3%DSS for 5 days. Body weight
ata represent mean ± SEM. *p < 0.05; **p < 0.01.
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Figure 7. The Inflammasome Regulates Intestinal Microbiota via Production of AMPs
(A) Feces collected from healthy WT, Aim2/, Nlrp3/, Il1b/, caspase-1/, and Il18/mice were diluted in PBS and plated on MacConkey agar. Colonies
were counted after 24 hr culture at 37C.
(legend continued on next page)
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metal chelators, thus they limit the growth of pathogens by
reducing the availability of essential trace elements such as
Zn2+ and Mn2+ (Gallo and Hooper, 2012). Similarly, Lcn2 was
shown to inhibit bacterial growth, including E. coli, by seques-
tering iron (Berger et al., 2006; Flo et al., 2004). Although the level
of Lcn2 in healthy Aim2/ and caspase-1/ mouse colons
were seen comparable to WT mice, its expression was strikingly
induced by cytokines IL-1b and IL-18, suggesting that Lcn2 may
be induced by the inflammasome and contribute to antimicrobial
host defense in the gut. Since Lcn2 is also induced by MyD88-
dependent pathways (Layoun et al., 2012), it is possible that an
increase in the E. coli burden in inflammasome-defective mice
may induce Lcn2 in the gut through activation of the TLR-
MyD88 pathways, making the level of Lcn2 indistinguishable in
comparison to WT mice. Taken together, these data suggest
that inflammasome-associated cytokines regulate the growth
E. coli and other gut microbiota through induction of multiple
AMPs.
Our study shows that AIM2 is expressed in different cell pop-
ulation including myeloid, lymphocyte, and epithelial cells in the
colon. However, how microbial DNA is delivered in the host cells
is unknown. Since the AIM2 inflammasome is activated by
diverse bacterial infections, it might be possible that gut bacteria
are taken up by intestinal epithelial and myeloid cells leading to
the release of bacterial DNA into the cytosol. A possibility of nat-
ural transfection of microbial DNA into intestinal immune and
epithelial cell should be investigated in future studies.
In summary, this study underscores the critical role the DNA
sensor AIM2 plays in regulating intestinal microbial community
and inflammation. We show that AIM2 activates the inflamma-
some via sensing bacterial DNA in the gut. Although a protective
role for the inflammasome in intestinal inflammatory disorders
has been known for last five years, the underlying mechanism
of inflammasome-mediated protection remains elusive. There-
fore, the findings of this study, showing regulation of gut micro-
biota by the inflammasome via production of antimicrobial
effector molecules, offer an insight into the pathogenesis of
inflammatory disorders of the gut. Moreover, the AIM2 inflamma-
some may serve as a therapeutic target for the regulation of
intestinal microbiota and inflammation.
EXPERIMENTAL PROCEDURES
Mice
Aim2/, Nlrp3/, Il18/, Caspase-1/ (Caspase-1/11/), and WT
(C57Bl6/J) micewere purchased from Jackson Laboratory. Il1b/mice (Shor-(B) Colitis was induced inWT,Aim2/, caspase-1/, and Il18/ (n = 8–10) mice
of a representative experiment; **p < 0.01, ***p < 0.001.
(C) Expression ofmBD2, Reg3b, Reg3g, S100a8, S100a9, and Lcn2 in colons coll
SEM; n = 7–10/group; *p < 0.05, **p < 0.01.
(D) Colonic crypts were cultured and treated with IL-1b or IL-18 for 4 hr. Expres
RT-PCR. Data represent mean ± SD of triplicate wells; *p < 0.05, **p < 0.01.
(E and F) Aim2/ mice were treated with either IL-18 (0.5 mg/mouse) or IL-1b (0.
cytokine infusion were cultured onMacConkey agar to count E. coli burden. (F)WT
were fed with 3% DSS for 5 days. IL-1b- and IL-18-treated mice further received
following DSS administration. Body weight changes were monitored daily. Data
(G) The proposed pathway for the AIM2 inflammasome-mediated regulation of in
See also Figure S7 and Table S1.
1934 Cell Reports 13, 1922–1936, December 1, 2015 ª2015 The Autnick et al., 1996) were kindly shared by Dr. Chandrashekhar Pasare at UT
Southwestern. All mice are maintained in a specific pathogen-free (SPF) facil-
ity. All studies were approved by the Institutional Animal Care and Use Com-
mittee of UT SouthwesternMedical Center andwere conducted in accordance
with the IACUC guidelines and NIH Guide for the Care and Use of Laboratory
Animals. All experiments were conducted with sex and age-matchedmice and
both male and female mice were included.
Colitis
Mice were treated with 3% (w/v) DSS (molecular mass 36–40 kDa; TdB Con-
sultancy) dissolved in sterile, distilled water ad libitum for the experimental
days 1–5 followed by normal drinking water until the end of the experiment.
Body weight, stool consistency, and the presence of occult blood were deter-
mined daily up to day 8. Scoring system for diarrhea and rectal bleeding is
described in the Supplemental Experimental Procedures.
Gene Expression
For gene expression analysis, tissues were homogenized in Trizol reagent
(Invitrogen). RNA was extracted according to the manufacturer’s instructions
and reverse transcripted into cDNA. qPCR assays were performed with
an CFX Connect real-time PCR detection system (Bio-Rad) using iTaq
Universal SYBR Green Supermix (Bio-Rad). Expression of GAPDH was
used as an endogenous control. Primers used for real-time PCR are listed in
Table S1.
Western Blot Analyses
For western blot analysis, total proteins from tissues or cells were homoge-
nized in RIPA lysis buffer containing protease and phosphatase inhibitor
(Roche), resolved by SDS-PAGE, and transferred onto a PVDF membrane.
Membranes were immunoblotted with rabbit antibodies against ERK (4695,
Cell Signaling), Phospho-ERK (4370, Cell Signaling) and LC3A (4599, Cell
Signaling), caspase-1 (AG-20B-0042, Adipogen), and AIM2 (13095,Cell
Signaling). b-actin or tubulin was used as a loading control.
Bacterial Genomic DNA Isolation and Microbiota Analysis
Frozen fecal samples were processed for DNA isolation using QIAamp Fast
DNA Stool Mini Kit (QIAGEN). To analysis the relative number of specific intes-
tinal bacterial groups, extracted bacterial genomic DNA was amplified for 16S
rDNAwith iTaq Universal SYBRGreen Supermix (Bio-Rad). Specific 16S rDNA
primer sequences for real-time PCR are listed in Table S2.
Statistical Analysis
Data are represented as mean ± SEM. Data were analyzed by Prism5
(GraphPad Software) and statistical significancewas determined by two-tailed
Student’s t test. p < 0.05 was considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.10.040.with 3%DSS. Body weights weremonitored daily. Data represent mean ± SEM
ected at days 0 and 3 was measured by real-time PCR. Data represent mean ±
sion of mBD2, Reg3b, Reg3g, S100a8, S100a9, and Lcn2 was measured by
3 mg/mouse) for 5 consecutive days. Feces collected at days 0, 3, and 6 after
(n = 5),Aim2/ (n = 3),Aim2/ (1L-1b) (n = 5), andAim2/ (IL-18) (n = 5) mice
IL-1b (0.3 mg/mouse) and IL-18 (0.5 mg/mouse) respectively at days 1, 3, and 5
represent mean ± SEM. *p < 0.05, **p < 0.01.
testinal inflammation and microbiota.
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